Back
BioAge Labs, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
61
BIOA
BioAge Labs, Inc.
Last Price:
$14.02
Seasonality Move:
-39.72%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atBioAge Labs, Inc. Stock Forecast
-
Is BioAge Labs, Inc. Stock Undervalued?The current BioAge Labs, Inc. [BIOA] share price is $14.03. The Score for BIOA is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
BIOA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will BioAge Labs, Inc. Stock Go Up Next Year?
Data Unavailable
BioAge Labs, Inc. Stock Rating
Data Unavailable
BioAge Labs, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
bioagelabs.com
52-Week Data
52-Week High:
16.43
52-Week Low:
2.88
Prediction Charts
Market Cap:
503M
Price in USD:
14.03
Volume:
420.9K
Beta:
1.48
Technical Analysis
SMA50:
10.41
SMA100:
7.81
SMA200:
5.99
52-Wk Change:
175.64%
Stock Predictions
-
Is BioAge Labs, Inc. stock public?Yes, BioAge Labs, Inc. is a publicly traded company.
-
What is the BioAge Labs, Inc. stock quote today?The BioAge Labs, Inc. stock price is 14.03 USD today.
-
How to buy BioAge Labs, Inc. stock online?You can buy BioAge Labs, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 12.50 | 12.30 | 12.99 | 12.26 |
| Dec-18 | 12.45 | 12.38 | 12.75 | 12.27 |
| Dec-19 | 12.41 | 13.39 | 13.41 | 12.36 |
| Dec-22 | 13.55 | 13.58 | 13.68 | 13.08 |
| Dec-24 | 13.38 | 14.08 | 14.46 | 13.38 |
| Dec-26 | 14.05 | 13.88 | 14.07 | 13.66 |
| Dec-29 | 13.94 | 13.84 | 14.02 | 13.52 |
| Dec-30 | 13.83 | 13.63 | 13.97 | 13.57 |
| Dec-31 | 13.56 | 13.23 | 13.70 | 13.11 |
| Jan-5 | 12.77 | 12.62 | 12.97 | 11.87 |
| Jan-6 | 12.70 | 15.41 | 16.18 | 12.31 |
| Jan-7 | 16.14 | 14.91 | 16.43 | 14.63 |
| Jan-8 | 14.66 | 13.92 | 15.08 | 13.91 |
| Jan-9 | 13.97 | 14.03 | 14.39 | 13.66 |
BioAge Labs, Inc. Earnings
Data Unavailable
BioAge Labs, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.61 per share, and a decrease next year of $0.33 per share.
* BioAge Labs, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.